BB Biotech
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
38 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
January 28, 2016 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 15, 2016 | Elliott Capital Advisors, L.P. | 0.00% | still open |
| December 14, 2016 | Elliott Capital Advisors, L.P. | 2.45% | still open |
| December 12, 2016 | Elliott Capital Advisors, L.P. | 2.33% | still open |
| November 16, 2016 | Elliott Capital Advisors, L.P. | 2.28% | still open |
| November 15, 2016 | Elliott Capital Advisors, L.P. | 2.46% | still open |
| November 3, 2016 | Elliott Capital Advisors, L.P. | 2.53% | still open |
| November 2, 2016 | Elliott Capital Advisors, L.P. | 2.43% | still open |
| October 25, 2016 | Elliott Capital Advisors, L.P. | 2.34% | still open |
| October 20, 2016 | Elliott Capital Advisors, L.P. | 2.23% | still open |
| September 21, 2016 | Elliott Capital Advisors, L.P. | 2.18% | still open |
| September 20, 2016 | Elliott Capital Advisors, L.P. | 2.21% | still open |
| September 16, 2016 | Elliott Capital Advisors, L.P. | 2.35% | still open |
| August 3, 2016 | Elliott Capital Advisors, L.P. | 2.45% | still open |
| July 27, 2016 | Elliott Capital Advisors, L.P. | 2.53% | still open |
| July 26, 2016 | Elliott Capital Advisors, L.P. | 2.69% | still open |
| July 21, 2016 | Elliott Capital Advisors, L.P. | 2.79% | still open |
| July 20, 2016 | Elliott Capital Advisors, L.P. | 2.87% | still open |
| July 12, 2016 | Elliott Capital Advisors, L.P. | 2.99% | still open |
| June 16, 2016 | Elliott Capital Advisors, L.P. | 2.79% | still open |
| June 14, 2016 | Elliott Capital Advisors, L.P. | 2.86% | still open |
| April 7, 2016 | Elliott Capital Advisors, L.P. | 2.90% | still open |
| March 30, 2016 | Elliott Capital Advisors, L.P. | 2.84% | still open |
| March 9, 2016 | Elliott Capital Advisors, L.P. | 2.72% | still open |
| March 8, 2016 | Elliott Capital Advisors, L.P. | 2.56% | still open |
| March 2, 2016 | Elliott Capital Advisors, L.P. | 2.40% | still open |
| March 1, 2016 | Elliott Capital Advisors, L.P. | 2.39% | still open |
| February 23, 2016 | Elliott Capital Advisors, L.P. | 2.23% | still open |
| February 19, 2016 | Elliott Capital Advisors, L.P. | 2.15% | still open |
| February 18, 2016 | Elliott Capital Advisors, L.P. | 2.08% | still open |
| February 17, 2016 | Elliott Capital Advisors, L.P. | 1.87% | still open |
| February 16, 2016 | Elliott Capital Advisors, L.P. | 1.73% | still open |
| February 12, 2016 | Elliott Capital Advisors, L.P. | 1.62% | still open |
| February 11, 2016 | Elliott Capital Advisors, L.P. | 1.55% | still open |
| February 10, 2016 | Elliott Capital Advisors, L.P. | 1.39% | still open |
| February 3, 2016 | Elliott Capital Advisors, L.P. | 1.26% | still open |
| February 1, 2016 | Elliott Capital Advisors, L.P. | 1.15% | still open |
| January 29, 2016 | Elliott Capital Advisors, L.P. | 1.01% | still open |
| January 28, 2016 | Elliott Capital Advisors, L.P. | 0.72% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Gerresheimer AG 6.46% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.23% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- TAG Immobilien AG 4.99% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BB Biotech, source Bundesanzeiger, data as at December 15, 2016, https://www.quivad.com/action/bb-biotech